We are pleased to announce that Medicilon will attend the RACI Congress 2026 – the flagship event of the Royal Australian Chemical Institute (RACI), bringing together chemical scientists, engineers, and industry leaders from across all RACI chemistry divisions.

Venue:Perth Convention & Exhibition Centre, Perth, Western Australia

Date:July 5-10, 2026

Medicilon Booth #9

RACI Congress 2026 is themed “Enabling Innovation in a Carbon Constrained World.” We look forward to showcasing our full-spectrum chemistry R&D platforms – and giving you a glimpse of how our integrated preclinical services can support your program from hit to IND.

Meet our team on site

• Jinna Cai – Chief Business Officer
• Yongmei Xu – VP of Business Development
• Tingshu Wang – Director of Business Development

What We Highlight at RACI 2026 – Chemistry & Technology Platforms

With 650+ IND approvals supported worldwide (FDA, NMPA, EMA, TGA, MFDS, PMDA), Medicilon provides a full spectrum of chemistry R&D services under one roof.

Medicinal Chemistry

• Focused library construction, activity screening & hit identification
• Lead generation, SAR development, lead optimization, PCC selection

Process Chemistry

• Reference scale-up, hundred gram to kilo gram synthesis
• Lead/PCC compound scale-up for animal studies
• Early stage process study of advanced compounds

Custom Synthesis

• Special reagents / intermediates synthesis
• Reference / standard synthesis
• Special impurities / metabolites synthesis
• Stable isotope internal standards synthesis

Technology Platforms

• Small molecule, TPD, XDC, RNAi, Peptide, AIDD…

Beyond Chemistry – Let’s Talk About Your Full Program

While our booth focuses on chemistry capabilities, Medicilon also offers biology, PD/PK, CMC, and regulatory support as part of our integrated preclinical CRO services. Come talk to Medicilon team – we’d be happy to discuss how we can support your entire journey from hit to IND, beyond chemistry.

See you in Perth!